A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT00287118 · COMPLETED
Trial details
- NCT number
- NCT00287118
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-27
- Primary completion
- 2006-05-30
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.